Literature DB >> 2660591

Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans.

L Lecavalier1, G Bolli, P Cryer, J Gerich.   

Abstract

To estimate the relative contributions of gluconeogenesis and glycogenolysis to the increase in hepatic glucose output (HGO) during glucose counterregulation under conditions simulating clinical insulin hypoglycemia, we induced moderate hypoglycemia (approximately 55 mg/dl) with a continuous infusion of insulin that resulted in physiological hyperinsulinemia (approximately 20 microU/ml) in eight normal volunteers and estimated gluconeogenesis by two methods: an isotopic approach in which appearance of plasma glucose derived from lactate was determined and another approach in which we infused alcohol along with insulin to block gluconeogenesis and used the exogenous glucose required to prevent greater hypoglycemia as an index of gluconeogenesis. Both methods gave similar results. Initially glycogenolysis accounted for approximately 85% of HGO; however, once hypoglycemia became established, the contribution of gluconeogenesis increased progressively to 77 +/- 10 (isotopic method) and 94 +/- 10% (alcohol method) of overall HGO. We conclude that in normal humans during moderate protracted hypoglycemia induced by physiological hyperinsulinemia, gluconeogenesis is the predominant factor responsible for the counterregulatory increase in HGO and that increased gluconeogenesis rather than increased glycogenolysis is the primary mechanism preventing development of greater hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660591     DOI: 10.1152/ajpendo.1989.256.6.E844

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  Hyperoxia blunts counterregulation during hypoglycaemia in humans: possible role for the carotid bodies?

Authors:  Erica A Wehrwein; Rita Basu; Ananda Basu; Timothy B Curry; Robert A Rizza; Michael J Joyner
Journal:  J Physiol       Date:  2010-10-04       Impact factor: 5.182

Review 2.  Essential elements of the native glucoregulatory system, which, if appreciated, may help improve the function of glucose controllers in the intensive care unit setting.

Authors:  Leon DeJournett
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

3.  Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade.

Authors:  James Leu; Min-Hui Cui; Harry Shamoon; Ilan Gabriely
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

Review 4.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

5.  Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.

Authors:  Jason J Winnick; Guillaume Kraft; Justin M Gregory; Dale S Edgerton; Phillip Williams; Ian A Hajizadeh; Maahum Z Kamal; Marta Smith; Ben Farmer; Melanie Scott; Doss Neal; E Patrick Donahue; Eric Allen; Alan D Cherrington
Journal:  J Clin Invest       Date:  2016-05-03       Impact factor: 14.808

6.  Forebrain and hindbrain effects of ethanol on counterregulatory responses to hypoglycemia in conscious rats.

Authors:  Darleen A Sandoval; Bin Gong; Stephen N Davis
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

7.  Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.

Authors:  Ling Hinshaw; Ashwini Mallad; Chiara Dalla Man; Rita Basu; Claudio Cobelli; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-07       Impact factor: 4.310

8.  Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.

Authors:  C Fanelli; S Calderone; L Epifano; A De Vincenzo; F Modarelli; S Pampanelli; G Perriello; P De Feo; P Brunetti; J E Gerich
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.

Authors:  H Shamoon; S Friedman; C Canton; L Zacharowicz; M Hu; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 10.  Hypoglycemias.

Authors:  F J Service
Journal:  West J Med       Date:  1991-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.